CLASS III ONGOING Drug recall · Reported 6 May 2026 · FDA Enforcement Report
Lidocaine Wound Gel (Benzalkonium Chloride recalled
Water-Jel Technologies is recalling Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), distributed nationwide in the US. The recall was initiated on 7 Apr 2026 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0509-2026
- FDA event ID
- 98737
- Recalling firm
- Water-Jel Technologies, Huntersville, NC
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- 7 Apr 2026
- FDA classified
- 30 Apr 2026
- Reported
- 6 May 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Pain Medication
Timeline
| 7 Apr 2026 | Recall initiated by company | |
| 30 Apr 2026 | Classified by FDA | +23 days |
| 6 May 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed PH Specifications
Product as listed by the FDA
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950
Where it was distributed
Nationwide in the USA
Stores named: CVS
Questions about this recall
Why was it recalled?
Failed PH Specifications
Which lots are affected?
Lots: A5014, A5018, A5019
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.